Abstract
Aim: To evaluate the effect of the glucagon-like peptide-1 analogue liraglutide on glycemic control, body weight, food intake, alpha- and beta-cell mass in adolescent transgenic pigs expressing a dominant-negative glucose-dependent insulinotropic polypeptide receptor (GIPRdn) (Renner et al., Diabetes 59:1228 – 1238, 2010).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
